Company addresses FDA requests regarding formulation excipient – Global site start-up activities continue, with first-patient-in for registrational Phase 1b study targeted for Q1 2026, subject to FDA ...
Patients as Partners® in Clinical Research Now Part of Questex’s Fierce Life Sciences Portfolio; First Conference to Put Patients at the Same Level as R&D Executives in a National Event Takes Place in ...
M&T Bank Corporation ( MTB) Goldman Sachs 2025 U.S. Financial Services Conference December 10, 2025 8:40 AM EST ...